Munich, Germany

Mathias Heikenwälder


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mathias Heikenwälder: Innovator in Vaccination Strategies

Introduction

Mathias Heikenwälder is a notable inventor based in Munich, Germany. He is recognized for his contributions to the field of vaccination strategies, particularly in enhancing the functionality of T cells. His innovative approach has the potential to significantly impact the treatment of various infections and tumors.

Latest Patents

Heikenwälder holds a patent for a vaccination strategy that utilizes TLR 9 and TLR 4 agonists. This invention focuses on using these agonists as multiplying jump agents to enhance the numbers and functionality of CD8 T cells. The strategy is designed for use in both prophylactic and therapeutic vaccines, particularly effective against acute and chronic infections with intracellular pathogens, as well as for anti-tumor vaccination. Additionally, the patent includes a kit containing a prime agent and a multiplying jump agent.

Career Highlights

Throughout his career, Mathias Heikenwälder has worked with prestigious institutions such as Klinikum Rechts der Isar der Technischen Universität München and Technische Universität München. His work in these organizations has allowed him to collaborate with leading experts in the field of immunology and vaccine development.

Collaborations

Heikenwälder has collaborated with notable colleagues, including Percy Knolle and Li-Rung Huang. These partnerships have contributed to the advancement of his research and the development of innovative vaccination strategies.

Conclusion

Mathias Heikenwälder's work in vaccination strategies exemplifies the importance of innovation in the medical field. His patented approach has the potential to enhance vaccine efficacy and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…